Fujifilm to Buy US Vaccine Maker

As Fujifilm boosts its supply of an experimental Ebola drug to help stem the spread of the virus, the Japanese firm said that it would buy a US vaccine maker. The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details. Japan's leading Nikkei business daily said the acquisition would be worth several billion yen (tens of millions ...